Pharmacotherapy in Liver Transplant Patients

Overview:

This activity will enable the learners to:
• Understand the types and management of allograft rejection in liver transplant recipients.
• Adopt the treatment options for different systemic and infectious diseases in liver transplant recipients.
• Identify the immunization in the liver transplant recipient.
• Appraise the important counseling points for liver transplant recipients.
• Identify the immunosuppressant drugs for liver transplant patients (dosing protocol, TDM, common side effects, possible drug-drug interactions, Toxicity (Tacrolimus/cyclosporine).

Participants who successfully complete this course will be awarded a certificate of participation.

Credits:

01.00

Date| Location | Time| Format:

Saturday, April 16, 2022 | Zoom Webinar | 01:00 pm – 02:00 pm

Accreditation Statement:
Shifa Foundation is accredited by the Accreditation Council of Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

Credit Designation Statement – American Medical Association (AMA):
Shifa Foundation designates this Live Activity for a maximum of 01.00 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement:
The Faculty/Speaker, CME Planning Committee, Reviewer, Moderator and any individual connected to this activity confirms that they do not have any relevant financial relationships with any commercial interests to disclose.

Additional Information:
Cancellation Policy:
SCOPE – Shifa Foundation reserves the right to cancel or postpone this program if necessary. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.